These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 80469)

  • 21. Antibodies against various forms of mildly oxidized low-density lipoprotein are not associated with carotid intima-media thickness in patients with primary hyperlipidemia.
    Tsouli SG; Kiortsis DN; Xydis V; Argyropoulou MI; Elisaf M; Tselepis AD
    Angiology; 2006; 57(5):615-22. PubMed ID: 17067985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological properties of bovine serum lipoproteins and chemical analysis of their protein moieties.
    Stead D; Welch VA
    J Dairy Sci; 1976 Jan; 59(1):1-8. PubMed ID: 175102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Myeloma, hyperlipidemia and xanthomatosis. II. Complementary research on the association between paraprotein and fast lipoproteins].
    Jacotot B; Nguyen-Trong T; Beaumont JL
    Nouv Rev Fr Hematol; 1965; 5(5):777-9. PubMed ID: 4221307
    [No Abstract]   [Full Text] [Related]  

  • 24. Advances in lipoprotein research: biochemical and clinical aspects.
    Schettler G; Seidel D; Greten H
    Med J Aust; 1973 May; 1(19):942-6. PubMed ID: 4351788
    [No Abstract]   [Full Text] [Related]  

  • 25. Assays for acetaldehyde-derived adducts in blood proteins based on antibodies against acetaldehyde/lipoprotein condensates.
    Latvala J; Melkko J; Parkkila S; Järvi K; Makkonen K; Niemelä O
    Alcohol Clin Exp Res; 2001 Nov; 25(11):1648-53. PubMed ID: 11707639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmunoassay of human high density lipoprotein apo-protein A-1.
    Fainaru M; Glangeaud MC; Eisenberg S
    Biochim Biophys Acta; 1975 Apr; 386(2):432-43. PubMed ID: 166665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of "free" apoA-I in serum: implications for immunological quantification of HDL and its apoproteins.
    Børresen AL; Berg K
    Artery; 1980; 7(2):139-60. PubMed ID: 7425861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biological consequences of lipoprotein modification].
    Wehr H
    Postepy Biochem; 1995; 41(3):201-5. PubMed ID: 7491360
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathophysiology of lipid transport disorders.
    Levy RI
    Postgrad Med J; 1975; 51(8):suppl 16-26. PubMed ID: 215978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial hyperlipidemias. Diagnosis and treatment.
    Fleischmajer R; Dowlati Y; Reeves JR
    Arch Dermatol; 1974 Jul; 110(1):43-50. PubMed ID: 4371196
    [No Abstract]   [Full Text] [Related]  

  • 31. The plasma lipoproteins: an overview.
    Levy RI
    Prog Clin Biol Res; 1976; 5():25-42. PubMed ID: 184478
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma lipoproteins and atherosclerosis in man: an immunohistochemical study.
    Hoff HF; Jackson RL; Titus JL; De Bakey ME; Gotto AM
    Cardiovasc Res Cent Bull; 1973; 12(2):29-39. PubMed ID: 4376051
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hyperlipemia and multiple myeloma. Report of a case].
    Gudiol F; Ariza J; Callis M
    Rev Clin Esp; 1978 May; 149(3):303-5. PubMed ID: 694102
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of the plasma lipoproteins and apoproteins of the Erythrocebus patas monkey.
    Mahley RW; Weisgraber KH; Innerarity T; Brewer HB
    Biochemistry; 1976 May; 15(9):1928-33. PubMed ID: 178359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production and characterization of monoclonal antibodies to oxidized LDL.
    Choi K; Lee HS; Chung HK
    Exp Mol Med; 1998 Mar; 30(1):41-5. PubMed ID: 9873821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A critical evaluation of the proposal that serum apolipoproteins are the major constituents of the human erythrocyte membrane.
    Carey C; Wang CS; Alaupovic P
    Biochim Biophys Acta; 1975 Aug; 401(1):6-14. PubMed ID: 167864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of hyperlipoproteinemia.
    Havel RJ
    Adv Exp Med Biol; 1972; 26(0):57-70. PubMed ID: 4370189
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of density gradient centrifugation for the separation of serum lipoproteins.
    Hinton RH; Al-Tamer Y; Mallinson A; Marks V
    Clin Chim Acta; 1974 Jun; 53(3):355-60. PubMed ID: 4367869
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and cytologic study of a 2nd case of xanthomatous IgA myeloma with circulating anti-lipoprotein antibodies].
    Aubert L; Arroyo H; Detolle P; Picard D; Cotte G
    Sem Hop; 1967 Nov; 43(48):3014-21. PubMed ID: 4296500
    [No Abstract]   [Full Text] [Related]  

  • 40. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.